INTRODUCTION
Cardiopulmonary bypass (CPB) and cardiac arrest allow the surgeon to perform controlled anastomoses during coronary artery bypass graft surgery (CABG). However, this comes at a cost. A systemic inflammatory response is a risk for organ damage and thus mortality and morbidity. Beating heart surgery, or off-pump CABG (OPCAB), was re-introduced to attenuate this effect. Many studies demonstrated very optimistic results in favour of OPCAB compared to CABG with conventional CPB. However, not everybody is convinced by the benefits, and this was addressed in a review on whether it would be beneficial to change to OPCAB. (1) In this study, the combined prevalence of mortality, myocardial infarction, stroke and new dialysis was 4%.
To improve this with even 25% would require 10 600 patients, which is impossible in the average private cardiac practice in South Africa. Many randomised controlled studies could not demonstrate clear benefits and surgeons are losing interest in the OPCAB technique. (2) This is confirmed by a review from the Cochrane Libraries. Based on the current evidence, CABG should be done with conventional CPB.
A new CPB system has been developed. The argument is that minimal extracorporeal circulation (MECC or minibypass) should reduce the inflammatory response associated with conventional CPB. (4) This system allows cardiac arrest, while maintaining the circulation. The lack of a venous reservoir with reduced priming volume, less cell trauma by the centrifugal pump driven by a magnet, and less blood-synthetic contact, all attribute to this possible beneficial effect. A reduction in markers of inflammation should result in reduced organ damage and therefore reduced postoperative complications. Volume 16 Number 1 "Evidence based medicine is the conscientious, explicit and judicious use of current best evidence in making decisions about care of individual patients". (5) The theoretical information regarding the beneficial effects of MECC, was thus introduced and applied in a private cardiac surgery practice.
The aim of this article was to report on 2 separate, but consecutive studies that were done to compare the effect of 2 CPB strategies in a population of patients who had their CABG done in a private practice. One study looked at the clinical outcome and a second study specifically compared a single blood-lactate level. These patients had their CABG done with either conventional cardiopulmonary bypass (CCPB) or minimal extracorporeal circulation (MECC). It is the clinical outcome that interests the surgeon, anaesthetist, referring cardiologist and obviously the patient. From a perfusion point of view, blood lactate is one way of verifying the adequacy of perfusion. (6) Blood lactate of 4.0mmol/l or higher during CPB, is an indication of tissue hypoperfusion, and is associated with more postoperative complications. 
METHODS
Two historical cohort analytical studies were done. For the first study, all patients who had their isolated CABG done with cardiopulmonary bypass by 1 surgeon (MJS), in 1 hospital from 2000 -2015, were included. Patients who required additional procedures were the only patients that were excluded. Conventional bypass (CCPB) was used from November 2000 until November 2011. In December 2011, all CCPB cases for CABG were switched to MECC. Again, all the patients operated on consecutively for isolated coronary artery disease until December 2015, were included. After December 2015, MECC was the CPB technique until July 2016.
The conventional bypass system used the Inspire ® oxygenator and a roller pump ( S5 Stöckert ® ). The priming solution was 2 500ml. The minisystem consisted of the Synergy ® membrane oxygenator, a centrifugal cone driven by the heart lung machine (S5 Stöckert ® ), and a closed loop with surface treatment (PH.I S.I.O.®). The priming solution was 500ml. Activated clotting time was maintained above 400 seconds in both techniques. The standard myocardial protection was intermittent, antegrade, cold 1:1 blood:cardioplegia. Systemic temperature drifted down to 33 -34°C, and patients were then actively rewarmed. Cell saving was used in every case. These 2 groups of CCPB and MECC patients were compared regarding clinical outcomes using univariate analysis, stepwise logistic regression, and a propensity score matched analysis. Lastly, the experience of the various role-players in theatre was added as part of this clinical appraisal. This was done with a simple, subjective questionnaire about the overall experience with minibypass. Table I . No significant differences were found in terms of mortality, morbidity and LOS. The CCPB patients had 46ml more mediastinal drainage over 48 hours compared to the MECC group. In both groups, 20% of patients required red blood cells from the blood bank. Acute kidney injury or a 50% rise in serum creatinine complicated 7.1% and 4.9%, respectively, in the CCPB and MECC groups (p=0.13). Some patients needed formal renal dialysis, 1.2% and 1.7% respectively (p=0.45).
It was clear that the basic demographic information of these 2 groups differed significantly (Table II) . Therefore in the propensity score matched analysis, 367 patients from the CCPB group were evenly matched with the 367 patients who had their CABG done with MECC. The mean propensity scores in both groups were 0.29. Two significant differences in the outcome were identified between these matched groups (Table III) . A rise in creatinine was now more prominent in the CCPB groups, with 10.4% of the patients having a significant increase in postoperative serum creatinine compared to only 4.9% from the MECC group. The Odd Ratio (OR) for patients to develop a higher serum creatinine was 0.42 with the MECC (95% Confidence Interval [CI] 0.21;0.78). This was confirmed with the stepwise logistic regression, where MECC was shown to have a protective effect on the kidneys, but not to the point of limiting the number of patients who required dialysis. Parsonette score and pre-operative Chronic Kidney Disease III (CKDIII) predicted renal failure requiring dialysis. In the stepwise logistic regression, MECC did not contribute to any other commonly reported outcome -except for the more favourable serum creatinine post-operatively.
The second difference from a statistical point of view was the dissimilarity in LOS (Table III) . CCPB patients stayed a mean of 6.4 days (median 5 days) and MECC patients 5.9 days (also a median 5 days). Although the medians are the same, there is some difference in the distributions. However, this difference in LOS was only when one compares percentage of patients who stayed longer than 6 days (CCPB 45.0% and MECC 36.3%). There was no difference in the 2 groups when the percentage of patients who stayed longer than 7 days (CCPB 21.3% and MECC 20.8%) was compared. The difference in LOS is probably, at most, half a day in favour of the MECC technique.
Two surgeons, 7 anaesthetists and 2 perfusionists answered a simple questionnaire to give information about their experience with MECC. All 11 specialists were aware of this bypass technique. One surgeon had a positive impression and 2 (Table IV) . Lactate was not associated with death or major morbidity and did not correlate with LOS.
Although lactate level on arrival in the ICU was the primary outcome, other comparisons were again made. The 2 groups did not differ in terms of their EuroSCORE II, BSA and CPBt, with p values of 0.31, 0.81 and 0.84 respectively ( Table V) . As far as outcomes were concerned, no difference was seen in mortality or morbidity between the groups CCPB and MECC (Table VI) . However, this second study confirmed the better LOS in patients who had their CABG done with MECC. The median LOS was 6 (7.6 mean) days and 5 (6.5 mean) days respectively (p=0.01 Mann-Whitney, 95%CI -1;0.0).
DISCUSSION
Since the start of this practice, by the end of 2000 CCPB was the CPB technique until December 2011. The CCPB technique was changed to MECC during December 2011 based on the advantages in the literature associated with MECC. A policy change was again introduced from July 2016 back to CCPB.
Apart from the combined numbers in review articles, this study is one of the larger, single institutional studies to compare CCPB with MECC. (8) The fact that a reduction in the inflammatory response would result in less adverse effects associated with CPB, made sense. (9) Unfortunately, the literature is not that convincing, and the clinical results are rather equivocal. This study's results are no different. Not only did the study by Svitek, et al. demonstrate no difference in the anti-inflammatory response, they also found no difference in the clinical outcome. (10) Admittedly, it was a small study that involved only 54 patients. Another study showed improvement in inflammatory markers following MECC. (11) Larger studies seem to illustrate a difference in favour of MECC. (12) At first glance, the impression is that this study would have a similar outcome to the 2 smaller studies mentioned. There was no difference in the common postoperative outcomes (Table I) . However, this study confirmed the perception that patients have become, over time, a higher postoperative risk for mortality. Although the Parsonette score is no longer used to assess operative risk, it was still useful to demonstrate the change in patient demographics (Table II) . Since the EuroSCORE changed in 2012 to an updated version (EuroSCORE II), Parsonette was applied in this first part of the study. It was considered to be inaccurate to use 2 different EuroSCOREs.
Once the 2 populations were comparable, 2 differences became clear. Renal function and LOS seemed to be better with MECC (Table III) . It was the serum creatinine that improved. MECC did not protect the kidneys enough to avoid dialysis. This observation is in line with Benedetto, et al. (13) Their study was also a propensity score matched analysis. They used a different criterion to diagnose kidney injury, but still the incidence of kidney injury was reported as 42% vs. 29% (for CCPB and MECC respectively). Again, there was no difference in the prevalence of patients requiring renal dialysis. In their series, the OR for renal injury with MECC was 0.61 (95%CI 0.38;0.97), whereas the OR for renal impairment postoperatively in the local series was 0.42 (95% CI 0.21;0.78).
Although the LOS was initially similar, the MECC group stayed shorter (mean 5.9 days as opposed to 6.4 days), when the 2 population groups were evenly matched (Table III) . It probably means that the higher risk (latter period) group (MECC) stayed the same number of days as the lesser risk (former period) group (CCPB) -but after the propensity score matching, the MECC patients stayed somewhat shorter. This half a day longer in hospital can probably be explained by the fact that more patients with CCPB had raised postoperative serum creatinine levels. A shorter LOS was also reported by Immer, et al. (14) The LOS dropped from 9.3 days -8.1 days with MECC. They did not however investigate postoperative renal function, except for the diuresis in the first 6 hours in the ICU, which was similar in the 2 bypass groups. In a large prospective study, no difference was seen in the LOS between CCPB and MECC patients. (15) A slim improvement in LOS with MECC was reported by Wang. (16) In their meta-analysis, the LOS in the 3 randomised trials was not statistically different, nor in the 2 cohort studies. However, the combination demonstrated a better LOS in favour of MECC, although it was only 18 hours.
Many studies report less mediastinal drainage and fewer units of red blood cells from a blood bank. (8) This study could not however confirm this (Tables I and III) . Post-operative drainage and red blood cell transfusion were also similar in the 2 groups in the study by Remedi. However, they reported a higher transfusion rate intra-operatively. (12) Low homologous red blood cell consumption in this practice has been reported previously. (17) Lactate is the conjugate base after lactic acid has lost a proton. This is the result of glucose and pyruvate metabolism in a hypoxic environment, but also when there is hypoperfusion of the liver as during CPB. (18) In contrast to this study, Puehler and colleagues established a difference in the lactate on arrival in the ICU between CCPB and MECC patients. (15) As a matter of interest, they found no difference between the lactate on arrival between MECC and OPCAB patients. They commented that the organ and tissue perfusion with MECC and OPCAB were better than with CCPB. They excluded patients in their series with a body mass index (BMI) of ≥30kg/m 2 . In the local study, the mean BMI was >30kg/m 2 (Table II) . This study demonstrated, as expected, a correlation between lactate and body surface area (BSA) and with CPBt (Table IV) .
The fact that most of the in-theatre specialists were less enthusiastic about minibypass can be attributed to the technical challenges. The heart acts as the reservoir for blood volume and if too much blood is drained, the bypass circulation stops. A fuller heart makes distal anastomosis more challenging. The 2 specialists who were keen to continue with MECC were a surgeon who had the impression that renal function recovered more quickly with MECC, and an anaesthetist who wanted to get more experience with MECC. The other specialists had reservations about MECC as a bypass technique, although MECC might have a place for selected patients.
Any amount of air in the venous system will also bring the circulation to a standstill. (19) The conventional system is much more forgiving. (20) The danger of air during true open-heart surgery is more real, and, therefore, as a local decision policy, no heart valve surgery with MECC was done. However, Baumbach, et al. and Wang, et al. reported a superior outcome of MECC in a population of valve surgery. (21, 16) It should also be borne in mind that with MECC there is no back-up of a cardiotomy sucker to collect spilled blood in the chest back to the circulation. All blood gets sucked away to the cell saver, where plasma (clotting factors) and platelets are washed out. This could lead to coagulation pathology and more bleeding. Some studies report no MECC in redo cases. (9, 13) Among the 1 939 patients in the first study of the local series, 10.7% had a second or further sternotomy. No adverse effects related to bleeding or air were documented in the local series.
LIMITATIONS
Acute renal impairment after cardiac surgery is complex. Parolari, et al. found 15 predictors of post-operative acute kidney injury. (22) Recently, it was also reported that determining the pre-operative renal function reserve (RFR), even among patients with a normal glomerular filtration rate, could predict post-operative renal impairment. (23) Not all of these predictors were available in the local series. Each patient's data are available in an existing and ongoing, self maintained Excel database. One person, the surgeon, collects this information and it is not audited by an independent person. Standard definitions are used, but they are still subjected to the surgeon's interpretation. Other variables are the number of anaesthetists and different perfusionists involved -each with his or her subtle differences in technique. The fact that the study was done over a long time span could also have had an influence on the outcomes. Larger numbers will always be preferred for better statistical power. A randomised trial would however probably be a better way to compare. Yet, patients were not individually selected for a bypass technique -but followed the standing policy, which changed twice over 17 years. Hopefully the issue of non-randomisation was further addressed with the propensity score matching. A cost analysis was not done, but the MECC pack is about 6.5% more expensive than the CCPB pack.
CONCLUSIONS
From the first study, it was clear that patients are currently at a higher operative mortality risk than a decade or 2 ago. There was not much difference in the outcome between the 2 techniques, even if one compares exactly similar groups -as was done with the propensity score matched analysis. One can conclude that MECC protects the kidneys, but not to the point where dialysis is avoided. The positive consequence of this improved renal function, is that, statistically, patients with MECC stayed for a slightly shorter time in hospital. It furthermore seems that at the time of the first study, the different role-players in theatre were less enthusiastic about the MECC procedure. From the second study, it would appear that at least the tissue perfusion, as measured by the once off blood lactate, is not worse with MECC. MECC is a safe alternative in patients who could benefit from a bypass technique that is kinder to the kidneys. This report does not necessarily contribute new information. The data from this study may be utilised to improve the power of future meta-analyses on this subject. Such a reflection is also important after application of information from elsewhere in a local context.
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